Posted 12 February, 2021
Bioventus Inc. IPO completed
IPO completed detected for ticker Nasdaq:BVS in a 424B4 filed on 12 February, 2021.
This is the initial public offering of shares of Class A common stock of Bioventus Inc.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Bioventus Inc.
Health Care/Life Sciences • Medical Equipment/Supplies
Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.Market Cap
$406M
View Company Details
$406M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.